Filter
124
Filtered Results: 124
Text search:
thrombocytopenia
after
vaccination
Featured
Recommendations
19
New Publications
26
Language
Document type
No document type
53
Guidelines
37
Fact sheets
13
Studies & Reports
9
Strategic & Response Plan
5
Manuals
4
Training Material
1
Situation Updates
1
Resource Platforms
1
Countries / Regions
India
10
Tanzania
6
Philippines
5
Rwanda
4
Brazil
4
Nepal
3
Latin America and the Carribbean
3
South Africa
3
Kenya
2
Nigeria
2
Global
2
Uganda
2
Ecuador
2
North Macedonia
1
Ukraine
1
Ghana
1
Zimbabwe
1
Africa
1
Germany
1
Western and Central Europe
1
Bangladesh
1
Papua New Guinea
1
Namibia
1
Authors & Publishers
Publication Years
Category
Countries
47
Clinical Guidelines
21
Public Health
4
Capacity Building
2
Women & Child Health
2
Pharmacy & Technologies
2
Toolboxes
COVID-19
39
Rapid Response
9
NTDs
8
HIV
7
Pharmacy
6
Refugee
4
Ebola & Marburg
3
TB
2
Zika
2
AMR
2
Caregiver
1
Conflict
1
Polio
1
13 July 2021
The module provides an overview of factors to consider when monitoring the safety of COVID-19 vaccines administered to pregnant and breastfeeding women. It describes how national routine AEFI surveillance should be adapted to cater for this specific group of population using both pass...
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn...
(Первинна та бустерна вакцинації) – з векторною вакциною – (вакцина Janssen® від COVID-19 виробництва Janssen Cilag International/Johnson & Johnson
Станом на: 14 лютого 2022 р. (даний інформаційн...
These are standing orders for eligible nurses and healthcare professionals to administer the Moderna COVID-19 vaccine to persons 18 years of age and older
updated version: 04/10/2021
Information about vaccine administration
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto...
Journal of The Association of Physicians of India, Vol. 63 November 2015,, pp.77-96
J Hepatol (2017), http://dx.doi.org/10.1016/j.jhep.2017.03.021
REG 174 INFORMATION FOR UK HEALTHCARE PROFESSIONALS
Guidelines for the Management of Typhoid Fever
recommended
WHO practical guidelines. 2nd edition
29 September 2021
